1613620-17-9Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
Paragraph 0635; 0636; 0637; 0638, (2014/06/25)
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HNE is implicated.
NOVEL COMPOUNDS
-
Page/Page column 112, (2014/07/08)
This invention relates to heterocyclic compounds, which are pyrimidinone derivatives having human neutrophil elastase inhibitory properties, and their use in therapy.
